University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Location status: Recruiting
NCT Number: NCT06976125
Urinary tract infection (UTI) is when bacteria enter the urinary system and cause an infection. UTIs cause symptoms including burning when peeing, a feeling of an increased urge to pee, and cloudy or strong-smelling urine. Sometimes, severe UTIs can also cause fever, abdominal pain, and/or lower back pain.
In the emergency department (ED), healthcare providers rely on symptoms, along with a urine analysis and a urine culture to diagnose a UTI. A urine analysis involves taking a sample of urine and analyzing different factors like color, acidity, presence of blood cells, presence of bacteria. An abnormal urine analysis increases the likelihood that patients might have a UTI, but it does not confirm it. A positive urine analysis will lead to provider's sending a sample of urine for a urine culture. A urine culture is used to grow whatever bacteria is in the collected urine. If growth is seen on the culture, then this confirms a patient has a UTI. This also specifies which bacteria grew on the culture. The lab can also take it a step further and do an antibiotic test to check which antibiotic the bacteria is sensitive to.
When a urine analysis comes back abnormal in an ER setting, patients are prescribed an antibiotic before the culture and antibiotic sensitivity tests come back. If a patients condition is not critical, they will be discharged home before the culture results come back. If the culture comes back positive, the pharmacists will evaluate the culture and antibiotic sensitivity tests, then call patients to inform them whether they are taking a suitable antibiotic.
This study aims to decrease the unnecessary use of antibiotics because this contributes to antibiotic resistance which is considered a global public health issue. Antibiotic resistance occurs when bacteria develop the ability to withstand certain antibiotics that used to be effective against them, which makes it difficult to treat the infection. One of the factors that increase the risk of antibiotic resistance is the overuse of antibiotics.
In this study, investigators will be incorporating a prediction model and a negative callback system to decrease unnecessary antibiotic use.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Cleveland, Ohio, 44106, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ER physician will input the necessary de-identified data into the decision aid application.
The decision aid determines if the patient has a high or low likelihood of having a positive urine culture. The patient with high likelihood of positive culture, will be prescribed empiric antibiotics per the UH guidelines for treating UTI in the ambulatory setting. Patients with a low likelihood of having a positive culture, will be discharged without antibiotics.
Study team members will give the patient a handout describing what will happen in the event of a positive or negative culture.
The culture call-back team, consisting of clinical pharmacists, will be notified.
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
Time frame: Up to 2 weeks
Time frame: Baseline
Time frame: Baseline
Time frame: Up to 2 weeks
Contact information is provided by the study sponsor or research team.
University Hospitals Cleveland Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07559318
Antiobiotic Stewardship, Communicable Diseases
Melun, France
View Trial DetailsNCT05711446
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New York, United States
View Trial DetailsNCT07435844
Calcinosis, Calcium Metabolism Disorders
Mariánské Lázně, Carlsbad Region, Czechia
View Trial DetailsNCT06702449
Bacterial Infections, Bacterial Infections and Mycoses
Lenexa, Kansas, United States
View Trial Details